{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:15:18Z","timestamp":1771481718512,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009388","name":"Jazan University","doi-asserted-by":"publisher","award":["FS10-046"],"award-info":[{"award-number":["FS10-046"]}],"id":[{"id":"10.13039\/100009388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jsps.2022.01.002","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T05:05:46Z","timestamp":1642050346000},"page":"237-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Study of influence of Catha edulis (Khat) chewing on oral pharmacokinetics of irbesartan in rats using a newly developed HPLC-UV method"],"prefix":"10.1007","volume":"30","author":[{"given":"Hassan A.","family":"Alhazmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa A.","family":"Bakri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahya A.","family":"Mohzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef G.","family":"Alshigaify","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al Bratty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadique A.","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziaur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waquar","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal Mohamed Elhassan","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2022.01.002_b0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1515\/chem-2020-0046","article-title":"Exploring the effect of khat (Catha edulis) chewing on the pharmacokinetics of the antiplatelet drug clopidogrel in rats using the newly developed LC-MS\/MS technique","volume":"18","author":"Alhazmi","year":"2020","journal-title":"Open Chem."},{"issue":"4","key":"10.1016\/j.jsps.2022.01.002_b0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/15376511003690307","article-title":"The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies","volume":"20","author":"Amacher","year":"2010","journal-title":"Toxicol. Mech. Meth."},{"issue":"6","key":"10.1016\/j.jsps.2022.01.002_b0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/bmc.1154","article-title":"HPLC determination of irbesartan in human plasma: its application to pharmacokinetic studies","volume":"23","author":"Bae","year":"2009","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jsps.2022.01.002_b0020","doi-asserted-by":"crossref","unstructured":"Bedada, W., de Andr\u00e9s, F., Engidawork, E., Hussein, J., LLerena, A., Aklillu, E., 2018. Effects of khat (catha edulis) use on catalytic activities of major drug-metabolizing cytochrome p450 enzymes and implication of pharmacogenetic variations. Sci. Rep. 8(1), 12726. DOI:10.1038\/s41598-018-31191-1.","DOI":"10.1038\/s41598-018-31191-1"},{"issue":"6","key":"10.1016\/j.jsps.2022.01.002_b0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/JCP.0000000000000413","article-title":"The psychostimulant khat (catha edulis) inhibits cyp2d6 enzyme activity in humans","volume":"35","author":"Bedada","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jsps.2022.01.002_b0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2217\/14750708.3.6.733","article-title":"Irbesartan: a review of its use alone and in combination with hydrochlorothiazide","volume":"3","author":"Borghi","year":"2006","journal-title":"Therapy"},{"key":"10.1016\/j.jsps.2022.01.002_b0035","first-page":"288","article-title":"Role of cytochrome p 4502C9 in irbesartan oxidation by human liver microsomes","volume":"27","author":"Bourrie","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.jsps.2022.01.002_b0040","first-page":"826","article-title":"Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist","volume":"265","author":"Cazaubon","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jsps.2022.01.002_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5507\/bp.2004.002","article-title":"Khat habit and its health effect. A natural amphetamine. Biomed. Pap","volume":"148","author":"Dhaifalah","year":"2004","journal-title":"Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.jsps.2022.01.002_b0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpba.2019.05.069","article-title":"An LC\u2013MS\/MS spectrometry method for the simultaneousdetermination of Rosuvastatin and Irbesartan in rat plasma: Insightinto pharmacokinetic and drug-drug interaction studies","volume":"174","author":"Elgawish","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jsps.2022.01.002_b0055","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/j.1875-9114.1996.tb03001.x","article-title":"A new class of antihypertensive therapy: angiotensin II receptor antagonists","volume":"16","author":"Ellis","year":"1996","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.jsps.2022.01.002_b0060","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/ptr.5832","article-title":"Pharmacological and toxicological effects of Catha edulis F. (Khat)","volume":"31","author":"Engidawork","year":"2017","journal-title":"Phyther. Res."},{"key":"10.1016\/j.jsps.2022.01.002_b0065","unstructured":"International Conference on Harmonization (ICH), Validation of Analytical Procedures: Text and Methodology, Q2 (R1), November, 2005. Available online: http:\/\/www.ipqpubs.com\/wp-content\/uploads\/2011\/09\/Q2_R1__Guideline.pdf."},{"issue":"2","key":"10.1016\/j.jsps.2022.01.002_b0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0009-9236(99)80059-9","article-title":"Steady-state (SS) pharmacokinetics (PK) of irbesartan alone and in combination with fluconazole (F)","volume":"65","author":"Kovasc","year":"1999","journal-title":"J. Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.jsps.2022.01.002_b0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s13318-018-0518-2","article-title":"Effect of 95% Ethanol Khat Extract and Cathinone on in vitro Human Recombinant Cytochrome P450 (CYP) 2C9, CYP2D6, and CYP3A4 Activity","volume":"44","author":"Lim","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jsps.2022.01.002_b0080","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"Am. Fam. Physician."},{"issue":"3","key":"10.1016\/j.jsps.2022.01.002_b0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/j.1552-4604.1998.tb04422.x","article-title":"Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects","volume":"38","author":"Marino","year":"1998","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2022.01.002_b0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.phytol.2015.05.016","article-title":"The psychostimulant drug khat (Catha edulis): A mini-review","volume":"13","author":"Nichols","year":"2015","journal-title":"Phytochem. Lett."},{"issue":"4","key":"10.1016\/j.jsps.2022.01.002_b0095","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/ijms17040580","article-title":"Hepatotoxicity Induced by \u201cthe 3Ks\u201d: Kava, Kratom and Khat","volume":"17","author":"Pantano","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jsps.2022.01.002_b0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1527-3466.1998.tb00354.x","article-title":"A review of the new angiotensin II-receptor antagonist irbesartan","volume":"16","author":"Powell","year":"1998","journal-title":"Cardiovasc. Drug Rev."},{"issue":"7","key":"10.1016\/j.jsps.2022.01.002_b0105","first-page":"S15","article-title":"Human pharmacokinetic\/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist","volume":"15","author":"Ruilope","year":"1997","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.jsps.2022.01.002_b0110","unstructured":"USFDA (2018). Bioanalytical method validation guidance for industry. Food and Drug Administration. Available from:https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf."},{"issue":"1","key":"10.1016\/j.jsps.2022.01.002_b0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.jsps.2022.01.002_b0120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.jsps.2022.01.002_b0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yrtph.2008.08.005","article-title":"Risk assessment of khat use in the Netherlands: a review based on adverse health effects, prevalence, criminal involvement and public order","volume":"52","author":"Pennings","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jsps.2022.01.002_b0130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.phymed.2010.08.012","article-title":"Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids","volume":"18","author":"Salminen","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jsps.2022.01.002_b0135","doi-asserted-by":"crossref","unstructured":"Madgula, V., Ali, Z., Smillie, T., Khan, I., Walker, L., Khan, S. Alkaloids and Saponins as Cytochrome P450 inhibitors from blue cohosh (Caulophyllum thalictroides) in an in vitro assay. Planta Med. 75, 329\u2013332.","DOI":"10.1055\/s-0028-1112207"},{"key":"10.1016\/j.jsps.2022.01.002_b0140","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1124\/dmd.115.065987","article-title":"High-throughput cytochrome P450 cocktail inhibition assay for assessing drug\u2013drug and drug-botanical interactions","volume":"43","author":"Li","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsps.2022.01.002_b0145","first-page":"566","article-title":"Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes","volume":"22","author":"Li","year":"1994","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.jsps.2022.01.002_b0155","first-page":"1","article-title":"Interpretation of Animal Dose and Human Equivalent Dose for Drug Development","volume":"31","author":"Shin","year":"2010","journal-title":"J. Korean Orient. Med."},{"key":"10.1016\/j.jsps.2022.01.002_b0150","unstructured":"US FDA, 2005. Guidance for Industry, Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Food and Drug Administration, Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), July 2005, Pharmacology and Toxicology. https:\/\/www.fda.gov\/media\/72309\/download."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016422000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016422000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:27:40Z","timestamp":1736184460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016422000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1319016422000020"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2022.01.002","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of influence of Catha edulis (Khat) chewing on oral pharmacokinetics of irbesartan in rats using a newly developed HPLC-UV method","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2022.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}